NASDAQ

Faeth Therapeutics, Inc. (FTH)

♥ 655 Thanks from members

Live price chart, market sentiment, and community perspectives for Faeth Therapeutics, Inc. (NASDAQ: FTH).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Lewis CantleyFounder: Locas PontisLeadership: Ed Cannon (CEO)Holder: Venture Capital InvestorsHolder: Arch Venture PartnersDietary Intervention TherapeuticsCancer Metabolism Pipelines#FTH#Faeth Therapeutics#cancer metabolism#biotech startup#NASDAQ healthcare